Breaking

The Social Reckoning review – Aaron Sorkin’s jittery sequel with all-new evil puppet Zuckerberg Former world No 1 Jon Rahm quits LIV before breakaway golf series relaunches NFL swallows $15K fine against 49ers Kyle Juszczyk for pretending to chug beer on field Winger Matondo joins Hibernian for rest of season Guardiola set to attend Man City's first home game since guilty verdict Travis Head hits back at Australia greats for firing a ‘bullet’ through current Test players While VCs crowd into San Francisco, Endeavor Catalyst raises $320M for founders ‘elsewhere’ Giants' Nabers doesn't practice, knee more 'sore' than usual Sydney’s ‘king of town hall’ ended up in a pauper’s grave. His support workers are shocked they weren’t told ‘A real-life moment from The Castle’: the retired Australian couple who took on a coal giant and won

NEWSREEL

The day, in 30-second reels.

--:--:--

World / Reel

World · Video brief

FDA says it will complete safety review of abortion pill in March

The FDA is set to finish its safety review of mifepristone by March, comparing its safety to surgical abortions. This analysis will involve data from approximately 100,000 women and is prompted by ongoing litigation and health claims.

NBC News· Oct 8, 2026 · 3:01 AM · 2 views

Video won't play? Watch on YouTube →

The FDA is set to finish its safety review of mifepristone by March, comparing its safety to surgical abortions. This analysis will involve data from approximately 100,000 women and is prompted by ongoing litigation and health claims. Full story and more reels: https://newsreel.video #news #breaking #abortion #FDA #health

Originally reported by NBC News. Read the full story →

More in World

New York court hears arguments in ongoing 9/11 families' lawsuit against Saudi Arabia

BBC News· 1 hour ago

Ukraine war briefing: Zelenskyy condemns ‘vile’ attacks from Russia that killed 20 in one apartment

The Guardian· 1 hour ago

USS Lincoln nearly home after more than 300 days at sea

NBC News· 2 hours ago

0 Comments

No comments yet. Be the first.